Global immunology company Argenx is acquiring Unnatural Products, a Santa Cruz-headquartered company focused on developing new treatments for certain types of rare cancers and diseases, in a deal that could be worth upward of $1 billion, Jessica M. Pasko reports in her weekly roundup of local business. She’s also got news on funding for Joby Aviation from the Air Force’s innovation arm, the launch of this year’s Lookout List and plenty more.
Leave a Reply